Atossa Therapeutics logo

Atossa Therapeutics Share Price Today

(NASDAQ: ATOS)

Atossa Therapeutics share price is $0.74 & ₹64.36 as on 6 Mar 2025, 2.30 'hrs' IST

$0.74

0.01

(1.49%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Atossa Therapeutics share price in Dollar and Rupees. Guide to invest in Atossa Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atossa Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Atossa Therapeutics share price movements

  • Today's Low: $0.72
    Today's High: $0.76

    Day's Volatility :4.96%

  • 52 Weeks Low: $0.72
    52 Weeks High: $2.31

    52 Weeks Volatility :68.82%

Atossa Therapeutics (ATOS) Returns

PeriodAtossa Therapeutics IncIndex (Russel 2000)
3 Months
-38.97%
0.0%
6 Months
-46.15%
0.0%
1 Year
-36.31%
0.0%
3 Years
-37.93%
-11.6%

Atossa Therapeutics (ATOS) Key Statistics

in dollars & INR

Previous Close
$0.7324
Open
$0.7222
Today's High
$0.758
Today's Low
$0.7204
Market Capitalization
$92.1M
Today's Volume
$66.3K
52 Week High
$2.31
52 Week Low
$0.7203
Revenue TTM
$0.0
EBITDA
$-29.5M
Earnings Per Share (EPS)
$-0.21
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-31.3%

How to invest in Atossa Therapeutics Stock (ATOS) from India?

It is very easy for Indian residents to invest directly in Atossa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atossa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atossa Therapeutics or ATOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atossa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atossa Therapeutics shares which would translate to 1.175 fractional shares of Atossa Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atossa Therapeutics, in just a few clicks!

Returns in Atossa Therapeutics (ATOS) for Indian investors in Rupees

The Atossa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atossa Therapeutics investment value today

Current value as on today

₹69,311

Returns

₹30,689

(-30.69%)

Returns from Atossa Therapeutics Stock

₹35,652 (-35.65%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Atossa Therapeutics (ATOS)

-57%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Atossa Therapeutics Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Atossa Therapeutics

  • BlackRock Inc

    7.76%

  • Vanguard Group Inc

    5.26%

  • Geode Capital Management, LLC

    2.24%

  • State Street Corp

    1.40%

  • Renaissance Technologies Corp

    1.24%

  • UBS Group AG

    0.89%

Analyst Recommendation on Atossa Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Atossa Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Atossa Therapeutics Stock (ATOS)

What analysts predicted

Upside of 710.81%

Target:

$6.00

Current:

$0.74

Insights on Atossa Therapeutics Stock (Ticker Symbol: ATOS)

  • Price Movement

    In the last 3 months, ATOS stock has moved down by -39.0%
  • ATOS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 90.5%
  • ATOS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 87.2%

Atossa Therapeutics Technicals Summary

Sell

Neutral

Buy

Atossa Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Atossa Therapeutics (ATOS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atossa Therapeutics Inc logo
-13.55%
-46.15%
-36.31%
-37.93%
-33.42%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atossa Therapeutics Inc logo
NA
NA
0.0
-0.22
-0.31
-0.2
NA
0.59
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atossa Therapeutics Inc logo
Buy
$92.1M
-33.42%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Atossa Therapeutics

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Organization
Atossa Therapeutics
Employees
12
CEO
Dr. Steven C. Quay FCAP, M.D., Ph.D.
Industry
Health Technology

Management People of Atossa Therapeutics

NameTitle
Dr. Steven C. Quay FCAP, M.D., Ph.D.
Chairman, CEO & President
Ms. Heather Rees CPA
Chief Financial Officer
Ms. Delly Behen P.H.R.
Senior Vice President of Administration & HR
Mr. Michael Parks
Vice President of Investor & Public Relations
Dr. Richard Graydon M.D., Ph.D.
Interim Chief Medical Officer

Important FAQs about investing in ATOS Stock from India :

What is Atossa Therapeutics share price today?

Atossa Therapeutics share price today stands at $0.74, Open: $0.72 ; Previous Close: $0.73 ; High: $0.76 ; Low: $0.72 ; 52 Week High: $2.31 ; 52 Week Low: $0.72.

The stock opens at $0.72, after a previous close of $0.73. The stock reached a daily high of $0.76 and a low of $0.72, with a 52-week high of $2.31 and a 52-week low of $0.72.

Can Indians buy Atossa Therapeutics shares?

Yes, Indians can invest in the Atossa Therapeutics (ATOS) from India.

With INDmoney, you can buy Atossa Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atossa Therapeutics at zero transaction cost.

How can I buy Atossa Therapeutics shares from India?

It is very easy to buy Atossa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atossa Therapeutics (ATOS) be purchased?

Yes, you can buy fractional shares of Atossa Therapeutics with INDmoney app.

What are the documents required to start investing in Atossa Therapeutics stocks?

To start investing in Atossa Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atossa Therapeutics Stock (ATOS)?

Today’s highest price of Atossa Therapeutics (ATOS) is $0.76.

Today’s lowest price of Atossa Therapeutics (ATOS) is $0.72.

What is today's market capitalisation of Atossa Therapeutics?

Today's market capitalisation of Atossa Therapeutics ATOS is 92.1M

What is the 52 Week High and Low Range of Atossa Therapeutics Stock (ATOS)?

  • 52 Week High

    $2.31

  • 52 Week Low

    $0.72

What are the historical returns of Atossa Therapeutics (ATOS)?

  • 1 Month Returns

    -13.55%

  • 3 Months Returns

    -46.15%

  • 1 Year Returns

    -36.31%

  • 5 Years Returns

    -33.42%

Who is the Chief Executive Officer (CEO) of Atossa Therapeutics ?

Dr. Steven C. Quay FCAP, M.D., Ph.D. is the current Chief Executive Officer (CEO) of Atossa Therapeutics.